Related Experiment Video
Updated: May 20, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Glycopeptide resistance in gram-positive cocci: a review
1Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry 605006, India.
Abstract:
Vancomycin-resistant enterococci (VRE) have emerged as important nosocomial pathogens in the past two decades all over the world and have seriously limited the choices available to clinicians for treating infections caused by these agents. Methicillin-resistant Staphylococcus aureus, perhaps the most notorious among the nosocomial pathogens, was till recently susceptible to vancomycin and the other glycopeptides. Emergence of vancomycin nonsusceptible strains of S. aureus has led to a worrisome scenario where the options available for treating serious infections due to these organisms are very limited and not well evaluated. Vancomycin resistance in clinically significant isolates of coagulase-negative staphylococci is also on the rise in many setups. This paper aims to highlight the genetic basis of vancomycin resistance in Enterococcus species and S. aureus. It also focuses on important considerations in detection of vancomycin resistance in these gram-positive bacteria. The problem of glycopeptide resistance in clinical isolates of coagulase-negative staphylococci and the phenomenon of vancomycin tolerance seen in some strains of Streptococcus pneumoniae has also been discussed. Finally, therapeutic options available and being developed against these pathogens have also found a mention.
Insights
Vancomycin resistance in bacteria like Enterococci (VRE) and Staphylococcus aureus is a growing global threat, limiting treatment options. This review explores the genetic basis, detection, and emerging therapies for these resistant gram-positive pathogens.
Area of Science:
- Clinical microbiology and infectious diseases
- Molecular biology of antimicrobial resistance
- Bacterial genetics and evolution
Background:
- Vancomycin-resistant enterococci (VRE) and vancomycin-nonsusceptible Staphylococcus aureus are significant nosocomial pathogens.
- The rise of these resistant strains severely restricts therapeutic choices for treating serious infections.
- Increasing vancomycin resistance is also observed in coagulase-negative staphylococci.
Purpose of the Study:
- To elucidate the genetic underpinnings of vancomycin resistance in Enterococcus species and Staphylococcus aureus.
- To discuss critical aspects of detecting vancomycin resistance in these gram-positive bacteria.
- To review glycopeptide resistance in coagulase-negative staphylococci and vancomycin tolerance in Streptococcus pneumoniae.
Main Methods:
- Review of existing literature on the genetic basis of vancomycin resistance.
- Analysis of diagnostic considerations for identifying vancomycin-resistant gram-positive bacteria.
- Synthesis of information on therapeutic strategies against emerging resistant pathogens.
Main Results:
- Detailed exploration of the genetic mechanisms conferring vancomycin resistance in key pathogens.
- Emphasis on the challenges and importance of accurate detection methods for resistance.
- Overview of current and developing treatment options for infections caused by these multidrug-resistant organisms.
Conclusions:
- Understanding the genetic basis of vancomycin resistance is crucial for combating its spread.
- Effective detection strategies are vital for appropriate patient management and infection control.
- Continued research into novel therapeutic agents is necessary to address the limited treatment landscape.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Development of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Gram-negative Bacterial Protein Secretion Systems

